Revelation Pharma (Osceola Capital) Acquires Harrow Health's Non‑Ophthalmic Compounding Business

Revelation Pharma (Osceola Capital) Acquires Five Compounding Pharmacies

January 27, 2022

Healthcare Services

Revelation Pharma, a PE-backed specialty pharmacy platform sponsored by Osceola Capital, completed add-on acquisitions of five compounding pharmacies: Innovation Compounding, Pencol Compounding Pharmacy, Pharmacy Specialists Compounding, Wise Pharmacy, and Convex Pharmacy. The deals expand Revelation's geographic footprint and clinical capabilities across key U.S. regions and will see some locations merged into existing Revelation businesses (e.g., Wise into Pencol; Convex into Everwell).

Revelation Pharma (Osceola Capital) Acquires Eagle Pharmacy and Lee Silsby Compounding Pharmacy

July 13, 2023

Healthcare Services

Osceola Capital’s platform company Revelation Pharma acquired Eagle Pharmacy (Hoover, Alabama) and Lee Silsby Compounding Pharmacy (Beachwood, Ohio), marking the seventeenth and eighteenth add-ons to the Revelation platform. The acquisitions expand Revelation’s 503A/503B compounding capabilities and geographic reach, adding scale, diversification, and capacity to serve patients, prescribers, and healthcare facilities nationwide.

Osceola Capital-Backed Revelation Pharma Acquires Everwell Specialty Pharmacy

March 23, 2021

Healthcare Services

Osceola Capital formed Revelation Pharma Corp as a pharmacy compounding platform in partnership with industry veteran Jacob Beckel and concurrently completed the acquisition of Pensacola-based Everwell Specialty Pharmacy. Revelation will pursue consolidation of 503A compounding pharmacies nationally, with Everwell serving as the initial platform asset focused on anti-infectives, specialty compounding and other therapeutic classes.

Revelation Pharma Acquires Wedgewood Pharmacy's Human-Health Book of Business

June 16, 2022

Healthcare Services

Osceola Capital's Revelation Pharma platform acquired the human-health book of business from Wedgewood Pharmacy, marking the eighth add-on for the Revelation platform. The deal allows Wedgewood to focus exclusively on veterinary compounding while expanding Revelation's national network of 503A/503B compounding pharmacies; terms were not disclosed.

Revelation Pharma Acquires Taylors Pharmacy and Key Compounding Pharmacy

July 9, 2024

Healthcare Services

Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Taylors Pharmacy (Florida) and Key Compounding Pharmacy (Federal Way, Washington). The acquisitions expand Revelation's coast-to-coast footprint and bring both pharmacies into its compounding network as Revelation assumes full operations; the sellers are the founders/owners Allen Deaver and HeeJoo Park.

Revelation Pharma Acquires Cascade Specialty Pharmacy

January 22, 2025

Healthcare Services

Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Cascade Specialty Pharmacy of Poulsbo, Washington. The acquisition expands Revelation Pharma's ENT and animal-health compounding capabilities and brings Cascade's existing customers and product lines into Revelation's national fulfillment network; Cascade's former owner Brandon Knott will remain involved as an ENT Allergy Product Specialist.